[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100552527":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":27,"centralContacts":32,"locations":41,"responsibleParty":77,"collaborators":81,"id":85,"slug":86,"hasResults":87,"nctId":88,"briefTitle":89,"officialTitle":90,"acronym":24,"eligibilityCriteria":91,"healthyVolunteers":87,"sex":92,"minAge":93,"maxAge":94,"enrollmentInfo":95,"targetDuration":24,"studyType":98,"phases":99,"briefSummary":102,"conditions":103,"keywords":105,"overallStatus":43,"whyStopped":24,"lastUpdateSubmitDate":109,"lastUpdatePostDateStruct":110,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":118},{"fullName":5,"class":6},"Universiti Sains Malaysia","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Postbiotic","EXPERIMENTAL","Postbiotic at 1g\u002Fday as an adjunct treatment against vaginal candidiasis in women for 4-weeks",[13],"Device: Postbiotic",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","Placebo at 1g\u002Fday as an adjunct treatment against vaginal candidiasis in women for 4-weeks",[19],"Device: Placebo",[21,25],{"type":22,"name":9,"description":11,"armGroupLabels":23,"otherNames":24},"DEVICE",[9],null,{"type":22,"name":15,"description":17,"armGroupLabels":26,"otherNames":24},[15],[28],{"name":29,"affiliation":30,"role":31},"Sumita Bhatia, MD","Sumita Hospital","PRINCIPAL_INVESTIGATOR",[33,37],{"name":29,"role":34,"phone":35,"phoneExt":24,"email":36},"CONTACT","91923569755","bhatiadrsumita@gmail.com",{"name":38,"role":34,"phone":39,"phoneExt":24,"email":40},"Min Tze Liong, PhD","604 653 2114","mintze.liong@usm.my",[42,61],{"facility":30,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"RECRUITING","Lucknow","Aliganj","226024","India","IN",{"type":50,"coordinates":51},"Point",[52,53],80.92313,26.83928,{"lat":53,"lon":52},[56,57,60],{"name":29,"role":34,"phone":35,"phoneExt":24,"email":36},{"name":58,"role":59,"phone":24,"phoneExt":24,"email":24},"Shandra Devi Balasubramaniam, PhD","SUB_INVESTIGATOR",{"name":38,"role":59,"phone":24,"phoneExt":24,"email":24},{"facility":62,"status":63,"city":64,"state":65,"zip":24,"country":66,"countryCode":67,"cosmosGeoPoint":68,"geoPoint":72,"contacts":73},"AIMST University","NOT_YET_RECRUITING","Bedong","Kedah","Malaysia","MY",{"type":50,"coordinates":69},[70,71],100.50876,5.72743,{"lat":71,"lon":70},[74],{"name":58,"role":34,"phone":75,"phoneExt":24,"email":76},"6044298000","shandradevi@aimst.edu.my",{"type":78,"investigatorFullName":79,"investigatorTitle":80,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"SPONSOR_INVESTIGATOR","Min-Tze LIONG","Professor",[82,84],{"name":62,"class":83},"UNKNOWN",{"name":30,"class":83},"100552527","phase-2-postbiotic-as-adjunct-treatment-for-vaginal-candidiasis-100552527",false,"NCT06474247","Postbiotic as Adjunct Treatment for Vaginal Candidiasis","Use of Postbiotic as Adjunct Treatment for Vaginal Candidiasis in Women","Inclusion criteria\n\n* Women who are sexually active\n* Confirmed with candidiasis as confirmed via clinical observations which include creamy whitish vaginal discharge and vulva-vaginal itchiness\n* Willing to commit throughout the experiment\n\nExclusion criteria\n\n* Long term medication (6 months or more) for any illnesses\n* Pregnant\n* Menopaused\n* Uterus and\u002For cervix removed\n* Cervical intraepithelial neoplasia\n* Vaginal suppository treatments within 4-weeks prior to entering the study\n* Oral medication for vaginal illnesses or any vaginal therapy such as hormones and estrogen within 4-weeks prior to entering the study\n* Have used vaginal estrogen cream, ring or tablet within 4-weeks prior to entering the study\n* Have used vaginal moisturizers, lubricants or homeopathic preparations within 4-weeks prior to entering the study\n* Have used spermicide agent within 4-weeks prior to entering the study\n* Have pelvic or any gynecologic surgery 6-months prior to entering the study","FEMALE","18 Years","81 Years",{"count":96,"type":97},118,"ESTIMATED","INTERVENTIONAL",[100,101],"PHASE2","PHASE3","This project aims to study the efficacy of intravaginal administration of postbiotic at 1g\u002Fday as an adjunct treatment against vaginal candidiasis in women for 4-weeks compared to placebo.",[104],"Vaginal Candidiasis",[106,107,108],"probiotic","postbiotic","vaginal candidiasis","2024-07-02",{"date":111,"type":112},"2024-07-05","ACTUAL",{"date":114,"type":112},"2024-06-02",{"date":116,"type":97},"2025-06-02",{"name":79,"class":6},2]